Scarica l'app Stockscreener
7.90
1.67%
0.13
Dopo l'orario di chiusura:
7.90
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché AVTR Giù?
Forum
Previsione
Precedente Chiudi:
$7.77
Aprire:
$7.73
Volume 24 ore:
5.10M
Relative Volume:
0.46
Capitalizzazione di mercato:
$5.34B
Reddito:
$6.55B
Utile/perdita netta:
$-530.20M
Rapporto P/E:
-10.16
EPS:
-0.7777
Flusso di cassa netto:
$495.00M
1 W Prestazione:
+3.00%
1M Prestazione:
-10.33%
6M Prestazione:
-42.63%
1 anno Prestazione:
-51.50%
Intervallo 1D:
$7.59
$8.065
Intervallo di 1 settimana:
$7.265
$8.065
Portata 52W:
$7.265
$16.17
Avantor Inc Stock (AVTR) Company Profile
Nome
Avantor Inc
Settore
Industria
Telefono
(610) 386-1700
Indirizzo
RADNOR CORPORATE CENTER, BUILDING ONE, RADNOR, PA
Compare AVTR vs ISRG, BDX, ALC, MDLN, RMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AVTR
Avantor Inc
|
7.90 | 5.34B | 6.55B | -530.20M | 495.00M | -0.7777 |
ISRG
Intuitive Surgical Inc
|
452.07 | 160.56B | 10.06B | 2.88B | 2.49B | 7.876 |
BDX
Becton Dickinson Co
|
154.51 | 43.95B | 21.92B | 1.76B | 2.63B | 6.1223 |
ALC
Alcon Inc
|
74.56 | 36.34B | 10.40B | 980.00M | 1.61B | 1.9749 |
MDLN
Medline Inc
|
44.28 | 35.94B | 28.43B | 1.16B | 1.26B | 1.4457 |
RMD
Resmed Inc
|
224.09 | 32.65B | 5.40B | 1.49B | 1.78B | 10.12 |
Avantor Inc Stock (AVTR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-03-06 | Downgrade | Barclays | Equal Weight → Underweight |
| 2026-01-05 | Downgrade | Evercore ISI | Outperform → In-line |
| 2025-12-17 | Downgrade | Jefferies | Hold → Underperform |
| 2025-12-15 | Downgrade | BofA Securities | Buy → Neutral |
| 2025-11-04 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2025-10-30 | Downgrade | Barclays | Overweight → Equal Weight |
| 2025-10-30 | Downgrade | JP Morgan | Overweight → Neutral |
| 2025-08-01 | Downgrade | Jefferies | Buy → Hold |
| 2025-04-29 | Downgrade | Goldman | Buy → Neutral |
| 2025-04-28 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2025-04-28 | Downgrade | Stifel | Buy → Hold |
| 2025-04-28 | Downgrade | TD Cowen | Buy → Hold |
| 2025-01-17 | Downgrade | UBS | Buy → Neutral |
| 2024-08-28 | Iniziato | Wells Fargo | Overweight |
| 2024-07-10 | Downgrade | Citigroup | Buy → Neutral |
| 2024-01-04 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2023-12-11 | Aggiornamento | TD Cowen | Market Perform → Outperform |
| 2023-09-28 | Iniziato | Bernstein | Mkt Perform |
| 2023-07-31 | Downgrade | Evercore ISI | Outperform → In-line |
| 2023-07-31 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2023-06-21 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-12-14 | Iniziato | Deutsche Bank | Hold |
| 2022-10-05 | Aggiornamento | Citigroup | Neutral → Buy |
| 2022-09-14 | Downgrade | Cowen | Outperform → Market Perform |
| 2022-09-09 | Downgrade | Cleveland Research | Buy → Neutral |
| 2022-08-25 | Iniziato | Credit Suisse | Neutral |
| 2022-04-04 | Downgrade | Citigroup | Buy → Neutral |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-08-30 | Ripresa | Raymond James | Outperform |
| 2021-08-05 | Ripresa | Credit Suisse | Outperform |
| 2021-08-02 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2021-06-04 | Iniziato | Goldman | Buy |
| 2021-04-29 | Aggiornamento | Stifel | Hold → Buy |
| 2021-03-03 | Iniziato | Barclays | Overweight |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2020-09-14 | Iniziato | Morgan Stanley | Overweight |
| 2020-07-15 | Aggiornamento | Cleveland Research | Neutral → Buy |
| 2020-01-08 | Iniziato | Wells Fargo | Overweight |
| 2020-01-07 | Iniziato | Citigroup | Buy |
| 2019-11-15 | Iniziato | Stifel | Hold |
| 2019-08-02 | Iniziato | Cleveland Research | Neutral |
| 2019-06-14 | Iniziato | Janney | Buy |
| 2019-06-12 | Iniziato | Raymond James | Outperform |
| 2019-06-11 | Iniziato | Goldman | Buy |
| 2019-06-11 | Iniziato | Guggenheim | Buy |
| 2019-06-11 | Iniziato | JP Morgan | Overweight |
| 2019-06-11 | Iniziato | Jefferies | Buy |
| 2019-06-11 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2019-06-11 | Iniziato | Piper Jaffray | Neutral |
| 2019-06-11 | Iniziato | RBC Capital Mkts | Outperform |
| 2019-06-11 | Iniziato | Robert W. Baird | Outperform |
| 2019-06-11 | Iniziato | SunTrust | Buy |
| 2019-06-11 | Iniziato | UBS | Buy |
| 2019-06-11 | Iniziato | William Blair | Outperform |
Mostra tutto
Avantor Inc Borsa (AVTR) Ultime notizie
Sectors Review: Is Avantor Inc still a buy after recent gains2026 Growth vs Value & Accurate Buy Signal Notifications - baoquankhu1.vn
Avantor® to Report First Quarter 2026 Earnings on Wednesday, April 29, 2026 - Sahm
Avantor, Inc. (AVTR) Q1 Earnings Meet Estimates - MSN
Why The Narrative Around Avantor (AVTR) Is Shifting After Target Cuts And Leadership Changes - finance.yahoo.com
Avantor to Report First Quarter 2026 Earnings on Wednesday, April 29, 2026 - Bitget
Avantor, Inc. (AVTR) stock price, news, quote and history - Yahoo Finance Singapore
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Avantor, Inc. (AVTR) and Encourages Shareholders to Learn More About the Investigation - accessnewswire.com
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Avantor (AVTR) and Veeva Systems (VEEV) - The Globe and Mail
2026-04-02 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Avantor, Inc. (AVTR) and Encourages Shareholders to Learn More About the Investigation | NYSE:AVTR | Press Release - Stockhouse
SG Americas Securities LLC Acquires 272,093 Shares of Avantor, Inc. $AVTR - MarketBeat
Avantor, Inc. (AVTR) Stock forecasts - Yahoo Finance UK
Avantor CFO R. Brent Jones to depart by late June - Investing.com Australia
Avantor, Inc. (AVTR) Stock Forecasts - finance.yahoo.com
Avantor stock holds at Market Perform as CFO departs, guidance intact - in.investing.com
How Investors Are Reacting To Avantor (AVTR) CFO Succession and Interim Finance Leadership Shift - simplywall.st
Avantor, Inc. Announces CFO Transition in April 2026 Press Release - Minichart
R. Brent Jones to Leave as Executive Vice President of Avantor, Inc., Effective on or Before June 24, 2026 - MarketScreener
Avantor Announces CFO Resignation and Interim Finance Leadership - TipRanks
Avantor (AVTR) plans CFO change, names interim finance chief and reaffirms 2026 guidance - Stock Titan
AVANTOR INCREAFFIRMS FISCAL 2026 FINANCIAL GUIDANCE - Moomoo
Avantor finance chief exits; Steve Eck to step in as interim CFO - Stock Titan
Avantor’s Stubblefield Talks Innovation, Sustainability With Axios - CSRwire
Avantor, Inc. (AVTR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Trade Recap: Does Avantor Inc align with a passive investing strategy2026 Reactions & Accurate Intraday Trade Tips - baoquankhu1.vn
Avantor, Inc. Hits New 52-Week Low at $7.27 Amidst Declining Performance - Markets Mojo
Why a $3.5 Million Bet Targets Avantor Amid a 54% Stock Drop - AOL.com
Bronstein, Gewirtz & Grossman, LLC Encourages Avantor, Inc. (AVTR) Shareholders to Inquire about Securities Investigation - accessnewswire.com
CONMED, Bruker, Waters Corporation, Avantor, and Bio-Techne Stocks Trade Down, What You Need To Know - Yahoo Finance
[ARS] Avantor, Inc. SEC Filing - Stock Titan
Form DEFA14A Avantor, Inc. - StreetInsider
Avantor (AVTR) 2026 proxy: new CEO, Revival plan and 2025 results - Stock Titan
Avantor taps veteran dealmaker as board eyes a high-stakes turnaround - MSN
Vanguard realigns holdings; reports 0 Avantor shares (AVTR) - Stock Titan
A Look At Avantor (AVTR) Valuation After Prolonged Share Price Weakness - Yahoo Finance
Assenagon Asset Management S.A. Takes Position in Avantor, Inc. $AVTR - marketbeat.com
EXCLUSIVE: Petrochemical Crunch From Iran War Isn't Hitting Hospitals Yet—But Analysts Say Costs For Critical Medical Supplies Could Rise Within Weeks - Benzinga
EXCLUSIVE: Petrochemical Crunch From Iran War Isn't Hitting Hospitals Yet—But Analysts Say Costs For Critical Medical Supplies Could Rise Within Weeks - Benzinga
Avantor stock hits 52-week low at $7.38 amid market challenges - Investing.com Australia
Bronstein, Gewirtz & Grossman, LLC Is Investigating Avantor, Inc. (AVTR) And Encourages Investors to Connect - accessnewswire.com
Avantor (NYSE:AVTR) Reaches New 12-Month LowTime to Sell? - MarketBeat
EDGAR Filing Documents for 0001628280-25-046936 - SEC.gov
Avantor, Inc. Hits New 52-Week Low at $7.39 Amidst Major Decline - Markets Mojo
Research Alert: CFRA Maintains Hold Rating On Shares Of Avantor - Moomoo
Bronstein, Gewirtz & Grossman, LLC Encourages Avantor, Inc. (AVTR) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Why a $3.5 Million Wager Focuses on Avantor After a 54% Share Price Decline - Bitget
Circumference Group's New Avantor Investment: A 3.5M Dollar PositionNews and Statistics - IndexBox
Avantor Inc stock faces pressure amid weak FY2026 guidance and market selloff - AD HOC NEWS
Avantor, Inc. $AVTR Shares Acquired by Greenhaven Associates Inc. - marketbeat.com
Avantor, Inc. (NYSE:AVTR) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
Avantor Inc Azioni (AVTR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.21%
0.07%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):